Markets:

Overview

News

Currencies

International

Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

99.71 +3.17 (+3.28%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

70 71 Next >

Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases ↗

August 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Genmab, BioNTech Join Forces For Cancer Immunotherapy Candidates ↗

August 05, 2022

Via Benzinga

A Flurry Of Employment News Drops Ahead Of Friday's Jobs Report ↗

August 04, 2022

(Thursday Market Open) The Bank of England (BoE) raised its key lending rate by 50 basis points, its biggest hike in 27 years.

Via Benzinga

Analyst Ratings for BioNTech ↗

July 29, 2022

Analysts have provided the following ratings for BioNTech (NASDAQ:BNTX) within the last quarter:

Via Benzinga

Here's Why BioNTech Stock Is Moving ↗

August 03, 2022

BioNTech SE - ADR (NASDAQ: BNTX) shares are trading higher in sympathy with Moderna Inc (NASDAQ: MRNA), which reported better-than-expected second-quarter results.

Via Benzinga

Equity Index Futures Rebound Despite Concerns Over OPEC And China ↗

August 03, 2022

(Wednesday Market Open) Stocks look to rebound as equity index futures point to a higher open and the dollar retreats from yesterday’s rally. But Fed speak and news out of OPEC and China present...

Via Benzinga

BioNTech Earnings Conference Call Is Coming Up, Here's What You Need To Know ↗

August 02, 2022

BioNTech (NASDAQ:BNTX) will host a conference call at 08:00 AM ET on August 8, 2022, to discuss Q2 2022 earnings results. How to Attend BioNTech (BNTX) Conference Call Follow this link to access the...

Via Benzinga

U.S. Manufacturing Picture Is Looking Brighter Than Europe's Right Now ↗

August 02, 2022

(Tuesday Market Open) Global jitters over U.S. House Speaker Nancy Pelosi’s expected visit to Taiwan dominated premarket trading with major U.S. equities indexes moving mildly lower before the open....

Via Benzinga

Monkeypox Stocks On The Move: What Investors Should Know About The Outbreak ↗

August 01, 2022

The World Health Organization has declared the 2022 outbreak of monkeypox a global health emergency. The monkeypox crisis isn't as severe as the COVID-19 pandemic, but it has a number of health care...

Via Benzinga

5 Value Stocks In The Healthcare Sector ↗

August 01, 2022

What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators...

Via Benzinga

Is The Energy Ready To Rebound? ↗

August 01, 2022

(Monday Market Open) Equity index futures turned a bit negative to start a new week and month, as investors are still digesting last week’s data with the S&P 500® index (SPX) near June highs.

Via Benzinga

Pfizer Ticks Higher As Covid Vaccine, Pill Carry Its Second-Quarter Beat ↗

July 28, 2022

The company projects strong sales of Comirnaty and Paxlovid in 2022.

Via Investor's Business Daily

Is Moderna's Cheaper Valuation A Buying Signal?

July 28, 2022

Moderna is one of the least expensive companies in the S&P 500 in terms of valuation. In this article, we'll examine other aspects of the company.

Via MarketBeat

Topics Stocks

Pfizer/BioNTech Start Ohase 2 Trial For COVID-19 Vaccine Against Omicron Subvariant ↗

July 27, 2022

Via Benzinga

Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design

July 27, 2022

From BioNTech SE

Via GlobeNewswire

BioNTech, Pfizer File For Clearance Over COVID-19 Vaccine Patent Dispute With CureVac ↗

July 26, 2022

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

July 25, 2022

What is a Value Stock?

Via Benzinga

WHO, UNICEF Sound Alarm As Pandemic Leads Largest Fall In Kids Vaccinations In 30 Years ↗

July 18, 2022

Via Benzinga

Why BioNTech Is Trading Higher Today Following A Stock Upgrade From SVB Securities Analyst ↗

July 13, 2022

SVB Securities, a division of SVB Financial Group (NASDAQ: SIVB), believes BioNTech SE – ADR (NASDAQ: BNTX) stock is trading below the most negative scenario for the COVID-19 vaccine mar

Via Benzinga

Twitter, Delta Air Lines And 45 Stocks Moving In Wednesday's Mid-Day Session ↗

July 13, 2022

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 122.4% to $6.76. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.

Via Benzinga

Why Cannabis Companies Traded Higher; Here's 60 Biggest Movers From Yesterday ↗

July 15, 2022

Gainers

Via Benzinga

Why 'Covid Fatigue' Isn't Enough To Keep BioNTech Down; Shares Surge On Upgrade ↗

July 13, 2022

BioNTech won an upgrade Wednesday. Here's what one analyst expects to drive growth.

Via Investor's Business Daily

AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, In Expert Review ↗

July 13, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022 ↗

July 13, 2022

Upgrades

Via Benzinga

Benzinga Before The Bell: Most Effective Covid-19 Vaccine, Google's Hiring Slowdown, Panasonic's New EV Battery And Other Top Financial Stories Wednesday, July 13 ↗

July 13, 2022

CNBC Bankrupt Crypto Firm Three Arrows Capital’s Assets Frozen By New York Judge

Via Benzinga

Amazon.com To $145? Here's The Biggest Price Target Changes For Wednesday ↗

July 13, 2022

SVB Leerink cut BioNTech SE (NASDAQ: BNTX) price target from $253 to $223. BioNTech shares rose 2.1% to $164.77 in pre-market trading.

Via Benzinga

Which COVID-19 Vaccine(s) Significantly Prevented Deaths - Read To Find Out ↗

July 13, 2022

Via Benzinga

U.S. Stock Futures Higher; All Eyes On Inflation Data ↗

July 13, 2022

Pre-open movers

Via Benzinga

The Good News For Moderna's Covid Shot Barely Moved Its Stock ↗

July 12, 2022

Moderna stock reacted minimally to positive results for its updated Covid booster.

Via Investor's Business Daily

Will Novavax's Covid Booster Thesis Play Out? What The Survey Says ↗

July 12, 2022

Novavax is hoping to launch an updated Covid booster shot.

Via Investor's Business Daily

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

70 71 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

BioNTech SE - American Depositary Shares (NQ:BNTX)

All News about BioNTech SE - American Depositary Shares

Starting at $3.75/week.

Subscribe Today